
Corporate
Responsibility
Our commitment to corporate responsibility is driven by an intense passion to transform cancer care and create a positive impact on our people, our patients, and our communities.
Our Approach to Corporate Responsibility
Guided by our values, we are committed to advancing breakthrough science and giving patients the opportunity to live healthier lives. This commitment is central to how we operate and foundational to our approach to corporate responsibility. We have laid out the following commitments as part of our corporate responsibility strategy:

Our Commitment
to Patients
At Guardant, we are committed to serving patients and dedicated to transforming the fight against cancer through innovation and compassion. We empower doctors with critical insights to help them better manage their patients, and together, we strive to accelerate breakthroughs in precision medicine to improve outcomes for patients worldwide.
More About Our MissionOur Guardant Access Program provides support to providers and patients to eliminate unexpected bills and confusing paperwork. The program manages the entire billing process for patients and is designed to limit out-of-pocket expenses for Comprehensive Genomic Profiling. The program also provides financial assistance to eligible patients and notifies them if their out-of-pocket expense for our tests is expected to exceed $100.
Our People
Our success relies on the diversity of backgrounds and ideas that inspire creativity and drive the development of innovative technologies our patients need. We strive to ensure a workplace where our differences are valued and every team member feels included and empowered.
We are proud to employ a diverse workforce comprised of approximately 54% women and 55% racially/ethnically diverse employees as of December 31, 2024. With support of the Board, we are developing company-wide initiatives focused on employee recruitment, retention, engagement, employee financial wellness, pay equity, and diversity and inclusion initiatives.

Corporate Governance

Our Board of Directors has established three key committees: the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee, all of which are composed entirely of independent directors. The Nominating and Corporate Governance Committee of our Board of Directors is responsible for overseeing our corporate responsibility strategy, initiatives, and policies.
Board Diversity
We are committed to enhancing the diversity of our Board so that they can exercise sound judgment using a variety of thoughts, backgrounds, and cultural experiences. As of April 2025, 30% of our directors are female and 40% of our directors self-identify as racially or ethnically diverse.
More About Our Approach to Corporate Governance